Neurorehabilitation Devices Market Forecast and Scope by 2031
The neurorehabilitation devices market size is projected to reach US$ 7,086.82 million by 2031 from US$ 2,725.76 million in 2023. The market is expected to register a CAGR of 12.7% during 2023–2031. Technological advancements in neurorehabilitation devices are likely to bring new trends in the neurorehabilitation devices market in the coming years.
Neurorehabilitation Devices Market Analysis
The increasing number of survivors of traumatic brain injuries (TBI) who are seeking effective rehabilitation solutions boosts the demand for neurorehabilitation devices, favoring market growth. Additionally, technological advancements in neurorehabilitation, such as robotics and brain-computer interfaces, enhance treatment efficacy and patient engagement, fueling the growth of the neurorehabilitation devices market. The growing occurrence of neurological disorders and an elderly population further contribute to market expansion. Furthermore, a greater understanding of the benefits of early and personalized rehabilitation therapies encourages healthcare providers to adopt innovative neurorehabilitation devices, ultimately enhancing patient outcomes and quality of life.
Neurorehabilitation Devices Market Overview
The neurorehabilitation devices market is rapidly evolving, fueled by advancements in technology and an expanding demand for effective rehabilitation solutions. The rising incidence of strokes and other neurodegenerative disorders among the global population further propels the growth of the market. As per an article titled "Assessing the perception of Parkinson's disease in Al-Ahsa, Saudi Arabia among the visitors of a public campaign: before and after survey," published in April 2024, the prevalence of Parkinson's disease (PD) in Saudi Arabia has been estimated to be 27 per 100,000 population. With aging, the likelihood of developing neurodegenerative conditions increases. This necessitates a robust rehabilitation framework to address the distinctive challenges faced by these individuals, including mobility issues, balance problems, and cognitive decline. Neurorehabilitation devices play a crucial role in improving the quality of life for people suffering from PD. These devices can assist with physical therapy, improve motor skills, and provide cognitive training.
According to an article titled "Stroke care in MENA: challenges, progress, and promising pathways," published in May 2023, in the country, between 8,000 and 10,000 individuals experience a stroke annually. Neurorehabilitation devices are critical for stroke recovery, addressing motor impairments, leveraging innovative technologies, and enhancing patient engagement through immersive therapies. In addition, as healthcare providers increasingly adopt innovative solutions to enhance patient outcomes, the neurorehabilitation devices market is poised for significant growth in the future.
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Neurorehabilitation Devices Market: Strategic Insights
Mrinal
Have a question?
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Neurorehabilitation Devices Market: Strategic Insights
Mrinal
Have a question?
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Neurorehabilitation Devices Market Drivers and Opportunities
Growing Number of Clinical Studies on Neurorehabilitation Devices
Clinical studies validate the safety and effectiveness of newly developed neurorehabilitation devices. They provide evidence that neurorehabilitation devices help enhance the quality of life of patients with neurological diseases. These studies encourage healthcare centers to integrate these devices into their treatment programs. For instance, "Clinical Study of a Wearable Remote Rehabilitation Training System for Patients with Stroke: Randomized Controlled Pilot Trial" was published in February 2023. The clinical study aimed to design a remote intelligent rehabilitation training system based on wearable devices and human-computer interaction training tasks and evaluate its safety and efficiency.
Researchers at the University of Kansas Medical Center are studying wearable technology as part of a national stroke recovery clinical trial. Experts are testing the effectiveness of wearable devices that stimulate electromagnetic energy in the brain and spinal cord, which may help decrease disability after a stroke.
In December 2022, a clinical trial study, "Effects of robotic rehabilitation using the Erigo device on patients with neurological injury: a systematic review and meta-analysis of randomized clinical trials," was published. The trial studied the effects of the Erigo robotic rehabilitation device on patients with neurological injury based on parameters such as safety, muscle strength, spasticity, functionality, gait/balance, and changes in the level of consciousness. The study concluded that Erigo, as a robotic rehabilitation device, is safe for patients with acquired brain injury and can reduce spasticity in patients with stroke. Thus, the increasing number of clinical studies on neurorehabilitation devices favors the growth of the market worldwide.
Strategic Initiatives by Market Players
Strategic initiatives taken by market players, such as mergers, acquisitions, partnerships, and collaborations, are likely to accelerate innovation, develop expertise, and expand market reach.
In April 2022, Blackrock Neurotech partnered with Phantom Neuro, a neurotech startup, to carry out research and development for Phantom Neuro's patent-pending Phantom X system, which offers patients highly accurate, almost real-time control of current and next-generation assistive devices, such as prosthetics and exoskeletons. This R&D partnership allows Phantom to use Blackrock's decades of experience in neurotechnology and develop biocompatible implantable sensors to bolster the Phantom X platform.
In December 2022, Ekso Bionics—a leader in exoskeleton technology for medical use—announced the acquisition of the Human Motion and Control ("HMC") Business Unit from Parker Hannifin Corporation. This acquisition will enhance Ekso's product portfolio and improve its strategic relationships with commercial and research partners such as Vanderbilt University. The partnership with Vanderbilt is expected to enhance its research capabilities and product development.
Thus, the strategic initiatives taken by the market players are likely to create lucrative opportunities for the neurorehabilitation market in the near future.
Neurorehabilitation Devices Market Report Segmentation Analysis
Key segments that contributed to the derivation of the neurorehabilitation devices market analysis are product type, application, and end user.
- Based on product type, the neurorehabilitation devices market is categorized into neurorobotic system, brain computer interface, non-invasive stimulators, and wearable devices. The brain computer interface segment held the largest share of the market in 2023.
- Based on application, the market is categorized into stroke, spinal cord injury, cerebral palsy, traumatic brain injury, Parkinson's disease, and others. The stroke segment held the largest neurorehabilitation devices market share in 2023.
- In terms of end user, the neurorehabilitation devices market is segmented into hospitals and clinics, rehabilitation centers, and home care. The hospitals and clinics segment dominated the market in 2023.
Neurorehabilitation Devices Market Share Analysis by Geography
The geographic scope of the neurorehabilitation devices market report is mainly divided into five regions: North America, Asia Pacific, Europe, Middle East & Africa, and South & Central America.
North America held a significant share of the market in 2023. The growth of the market is driven by the growing prevalence of neurological disorders, such as cerebral palsy and spinal cord injury, followed by the surging technological advancement in the field of neurorehabilitation devices. In addition, new product launches and increasing research and development for advancing neurorehabilitation devices are projected to accelerate the growth of the neurorehabilitation devices market in the region.
According to the Brain Injury Canada report, TBI is the leading cause of disability, with 2% of Canadians associated with 18,000 hospitalizations annually. According to the Brain Injury Association of Waterloo-Wellington, TBI occurs in 500 out of 100,000 people yearly in Canada; over 6,000 patients become permanently disabled each year due to a TBI. The integration of neurorehabilitation devices is a crucial part of the recovery process for TBI patients. These devices, including robotic systems and cognitive aids, facilitate targeted rehabilitation by providing personalized therapy that enhances motor skills and cognitive functions.
Neurorehabilitation Devices Market Report Scope
Neurorehabilitation Devices Market News and Recent Developments
The neurorehabilitation devices market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. A few of the developments in the neurorehabilitation devices market are listed below:
- Ekso Bionics Holdings, Inc. received 510(k) clearance from the US Food and Drug Administration (FDA) to market its EksoNR robotic exoskeleton for use with multiple sclerosis patients. It is the first exoskeleton device to receive FDA clearance for rehabilitation in patients with multiple sclerosis. This indication significantly expands the device's use to a broader group of patients. In addition to its FDA clearances, EksoNR is CE-marked and available in Europe. (Source: Ekso Bionics Holdings, Inc., Press Release, June 2022)
- DIH, a leading global robotics and virtual reality (VR) technology company for advanced rehabilitation care, announced the shift of the strategic commercial agreement made in 2020 with Gorbel, Inc. into the complete purchase of its Rehabilitation Division. All three SafeGait devices will continue to be manufactured in the United States and are now listed with the FDA under DIH Technology, Inc. (Source: DIH, Press Release, October 2022)
Neurorehabilitation Devices Market Report Coverage and Deliverables
The "Neurorehabilitation Devices Market Size and Forecast (2021–2031)" report provides a detailed analysis of the market covering below areas:
- Neurorehabilitation devices market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
- Neurorehabilitation devices market trends, as well as market dynamics such as drivers, restraints, and key opportunities
- Detailed PEST and SWOT analysis
- Neurorehabilitation devices market analysis covering key market trends, global and regional framework, major players, regulations, and recent market developments
- Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments for the neurorehabilitation devices market
- Detailed company profiles
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
North America dominated the neurorehabilitation devices market in 2023.
Blackrock Microsystems Inc, Hocoma AG, Medtronic Plc, Tyromotion GmbH, Ekso Bionics Holdings Inc, BIONIK, Abbott Laboratories, Renishaw Plc, EMOTIV, and BioXtreme Ltd are among the key players operating in the neurorehabilitation devices market.
The increasing prevalence of neurological diseases worldwide and the growing number of clinical studies on neurorehabilitation devices are the most influential factors responsible for the market growth.
The global neurorehabilitation devices market is estimated to register a CAGR of 12.7% during the forecast period.
The estimated value of the neurorehabilitation devices market can reach US$ 7,086.82 million by 2031.
1. Introduction
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
3.2.1 Hypothesis formulation:
3.2.2 Macro-economic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country level data:
4. Neurorehabilitation Devices Market Landscape
4.1 Overview
4.2 PEST Analysis
4.3 Average Selling Price
5. Neurorehabilitation Devices Market – Key Market Dynamics
5.1 Neurorehabilitation Devices Market – Key Market Dynamics
5.2 Market Drivers
5.2.1 Increasing Prevalence of Neurological Diseases
5.2.2 Growing Number of Clinical Studies on Neurorehabilitation Devices
5.3 Market Restraints
5.3.1 High Costs Associated with Neurorehabilitation Devices
5.4 Market Opportunities
5.4.1 Strategic Initiatives by Market Players
5.5 Future Trends
5.5.1 Technological Advancements
5.6 Impact of Drivers and Restraints:
6. Neurorehabilitation Devices Market – Global Market Analysis
6.1 Neurorehabilitation Devices Market Revenue (US$ Million), 2021–2031
6.2 Neurorehabilitation Devices Market Forecast Analysis
7. Neurorehabilitation Devices Market Analysis – by Product Type
7.1 Neurorobotic System
7.1.1 Overview
7.1.2 Neurorobotic System: Neurorehabilitation Devices Market – Revenue and Forecast to 2031 (US$ Million)
7.2 Brain Computer Interface
7.2.1 Overview
7.2.2 Brain Computer Interface: Neurorehabilitation Devices Market – Revenue and Forecast to 2031 (US$ Million)
7.3 Non-invasive Stimulators
7.3.1 Overview
7.3.2 Non-invasive Stimulators: Neurorehabilitation Devices Market – Revenue and Forecast to 2031 (US$ Million)
7.4 Wearable Devices
7.4.1 Overview
7.4.2 Wearable Devices: Neurorehabilitation Devices Market – Revenue and Forecast to 2031 (US$ Million)
8. Neurorehabilitation Devices Market Analysis – by Application
8.1 Stroke
8.1.1 Overview
8.1.2 Stroke: Neurorehabilitation Devices Market – Revenue and Forecast to 2031 (US$ Million)
8.2 Traumatic Brain Injury
8.2.1 Overview
8.2.2 Traumatic Brain Injury: Neurorehabilitation Devices Market – Revenue and Forecast to 2031 (US$ Million)
8.3 Spinal Cord Injury
8.3.1 Overview
8.3.2 Spinal Cord Injury: Neurorehabilitation Devices Market – Revenue and Forecast to 2031 (US$ Million)
8.4 Parkinsons Disease
8.4.1 Overview
8.4.2 Parkinsons Disease: Neurorehabilitation Devices Market – Revenue and Forecast to 2031 (US$ Million)
8.5 Cerebral Palsy
8.5.1 Overview
8.5.2 Cerebral Palsy: Neurorehabilitation Devices Market – Revenue and Forecast to 2031 (US$ Million)
8.6 Others
8.6.1 Overview
8.6.2 Others: Neurorehabilitation Devices Market – Revenue and Forecast to 2031 (US$ Million)
9. Neurorehabilitation Devices Market Analysis – by End User
9.1 Rehabilitation Centers
9.1.1 Overview
9.1.2 Rehabilitation Centers: Neurorehabilitation Devices Market – Revenue and Forecast to 2031 (US$ Million)
9.2 Hospitals and Clinics
9.2.1 Overview
9.2.2 Hospitals and Clinics: Neurorehabilitation Devices Market – Revenue and Forecast to 2031 (US$ Million)
9.3 Home Care
9.3.1 Overview
9.3.2 Home Care: Neurorehabilitation Devices Market – Revenue and Forecast to 2031 (US$ Million)
10. Neurorehabilitation Devices Market – Geographical Analysis
10.1 Overview
10.2 North America
10.2.1 North America Neurorehabilitation Devices Market Overview
10.2.2 North America: Neurorehabilitation Devices Market – Revenue and Forecast to 2031 (US$ Million)
10.2.3 North America: Neurorehabilitation Devices Market –Forecast Analysis – by Product Type
10.2.4 North America: Neurorehabilitation Devices Market – Revenue and Forecast Analysis – by Application
10.2.5 North America: Neurorehabilitation Devices Market – Revenue and Forecast Analysis – by End User
10.2.6 North America: Neurorehabilitation Devices Market – Revenue and Forecast Analysis – by Country
10.2.6.1 United States: Neurorehabilitation Devices Market – Revenue and Forecast to 2031 (US$ Million)
10.2.6.1.1 United States: Neurorehabilitation Devices Market Breakdown, by Product Type
10.2.6.1.2 United States: Neurorehabilitation Devices Market Breakdown, by Application
10.2.6.1.3 United States: Neurorehabilitation Devices Market Breakdown, by End User
10.2.6.2 Canada: Neurorehabilitation Devices Market – Revenue and Forecast to 2031 (US$ Million)
10.2.6.2.1 Canada: Neurorehabilitation Devices Market Breakdown, by Product Type
10.2.6.2.2 Canada: Neurorehabilitation Devices Market Breakdown, by Application
10.2.6.2.3 Canada: Neurorehabilitation Devices Market Breakdown, by End User
10.2.6.3 Mexico: Neurorehabilitation Devices Market – Revenue and Forecast to 2031 (US$ Million)
10.2.6.3.1 Mexico: Neurorehabilitation Devices Market Breakdown, by Product Type
10.2.6.3.2 Mexico: Neurorehabilitation Devices Market Breakdown, by Application
10.2.6.3.3 Mexico: Neurorehabilitation Devices Market Breakdown, by End User
10.3 Europe
10.3.1 Europe Neurorehabilitation Devices Market Overview
10.3.2 Europe: Neurorehabilitation Devices Market – Revenue and Forecast to 2031 (US$ Million)
10.3.3 Europe: Neurorehabilitation Devices Market –Forecast Analysis – by Product Type
10.3.4 Europe: Neurorehabilitation Devices Market – Revenue and Forecast Analysis – by Application
10.3.5 Europe: Neurorehabilitation Devices Market – Revenue and Forecast Analysis – by End User
10.3.6 Europe: Neurorehabilitation Devices Market – Revenue and Forecast Analysis – by Country
10.3.6.1 United Kingdom: Neurorehabilitation Devices Market – Revenue and Forecast to 2031 (US$ Million)
10.3.6.1.1 United Kingdom: Neurorehabilitation Devices Market Breakdown, by Product Type
10.3.6.1.2 United Kingdom: Neurorehabilitation Devices Market Breakdown, by Application
10.3.6.1.3 United Kingdom: Neurorehabilitation Devices Market Breakdown, by End User
10.3.6.2 Germany: Neurorehabilitation Devices Market – Revenue and Forecast to 2031 (US$ Million)
10.3.6.2.1 Germany: Neurorehabilitation Devices Market Breakdown, by Product Type
10.3.6.2.2 Germany: Neurorehabilitation Devices Market Breakdown, by Application
10.3.6.2.3 Germany: Neurorehabilitation Devices Market Breakdown, by End User
10.3.6.3 France: Neurorehabilitation Devices Market – Revenue and Forecast to 2031 (US$ Million)
10.3.6.3.1 France: Neurorehabilitation Devices Market Breakdown, by Product Type
10.3.6.3.2 France: Neurorehabilitation Devices Market Breakdown, by Application
10.3.6.3.3 France: Neurorehabilitation Devices Market Breakdown, by End User
10.3.6.4 Spain: Neurorehabilitation Devices Market – Revenue and Forecast to 2031 (US$ Million)
10.3.6.4.1 Spain: Neurorehabilitation Devices Market Breakdown, by Product Type
10.3.6.4.2 Spain: Neurorehabilitation Devices Market Breakdown, by Application
10.3.6.4.3 Spain: Neurorehabilitation Devices Market Breakdown, by End User
10.3.6.5 Italy: Neurorehabilitation Devices Market – Revenue and Forecast to 2031 (US$ Million)
10.3.6.5.1 Italy: Neurorehabilitation Devices Market Breakdown, by Product Type
10.3.6.5.2 Italy: Neurorehabilitation Devices Market Breakdown, by Application
10.3.6.5.3 Italy: Neurorehabilitation Devices Market Breakdown, by End User
10.3.6.6 Rest of Europe: Neurorehabilitation Devices Market – Revenue and Forecast to 2031 (US$ Million)
10.3.6.6.1 Rest of Europe: Neurorehabilitation Devices Market Breakdown, by Product Type
10.3.6.6.2 Rest of Europe: Neurorehabilitation Devices Market Breakdown, by Application
10.3.6.6.3 Rest of Europe: Neurorehabilitation Devices Market Breakdown, by End User
10.4 Asia Pacific
10.4.1 Asia Pacific Neurorehabilitation Devices Market Overview
10.4.2 Asia Pacific: Neurorehabilitation Devices Market – Revenue and Forecast to 2031 (US$ Million)
10.4.3 Asia Pacific: Neurorehabilitation Devices Market –Forecast Analysis – by Product Type
10.4.4 Asia Pacific: Neurorehabilitation Devices Market – Revenue and Forecast Analysis – by Application
10.4.5 Asia Pacific: Neurorehabilitation Devices Market – Revenue and Forecast Analysis – by End User
10.4.6 Asia Pacific: Neurorehabilitation Devices Market – Revenue and Forecast Analysis – by Country
10.4.6.1 China: Neurorehabilitation Devices Market – Revenue and Forecast to 2031 (US$ Million)
10.4.6.1.1 China: Neurorehabilitation Devices Market Breakdown, by Product Type
10.4.6.1.2 China: Neurorehabilitation Devices Market Breakdown, by Application
10.4.6.1.3 China: Neurorehabilitation Devices Market Breakdown, by End User
10.4.6.2 Japan: Neurorehabilitation Devices Market – Revenue and Forecast to 2031 (US$ Million)
10.4.6.2.1 Japan: Neurorehabilitation Devices Market Breakdown, by Product Type
10.4.6.2.2 Japan: Neurorehabilitation Devices Market Breakdown, by Application
10.4.6.2.3 Japan: Neurorehabilitation Devices Market Breakdown, by End User
10.4.6.3 India: Neurorehabilitation Devices Market – Revenue and Forecast to 2031 (US$ Million)
10.4.6.3.1 India: Neurorehabilitation Devices Market Breakdown, by Product Type
10.4.6.3.2 India: Neurorehabilitation Devices Market Breakdown, by Application
10.4.6.3.3 India: Neurorehabilitation Devices Market Breakdown, by End User
10.4.6.4 Australia: Neurorehabilitation Devices Market – Revenue and Forecast to 2031 (US$ Million)
10.4.6.4.1 Australia: Neurorehabilitation Devices Market Breakdown, by Product Type
10.4.6.4.2 Australia: Neurorehabilitation Devices Market Breakdown, by Application
10.4.6.4.3 Australia: Neurorehabilitation Devices Market Breakdown, by End User
10.4.6.5 South Korea: Neurorehabilitation Devices Market – Revenue and Forecast to 2031 (US$ Million)
10.4.6.5.1 South Korea: Neurorehabilitation Devices Market Breakdown, by Product Type
10.4.6.5.2 South Korea: Neurorehabilitation Devices Market Breakdown, by Application
10.4.6.5.3 South Korea: Neurorehabilitation Devices Market Breakdown, by End User
10.4.6.6 Rest of APAC: Neurorehabilitation Devices Market – Revenue and Forecast to 2031 (US$ Million)
10.4.6.6.1 Rest of APAC: Neurorehabilitation Devices Market Breakdown, by Product Type
10.4.6.6.2 Rest of APAC: Neurorehabilitation Devices Market Breakdown, by Application
10.4.6.6.3 Rest of APAC: Neurorehabilitation Devices Market Breakdown, by End User
10.5 Middle East and Africa
10.5.1 Middle East and Africa Neurorehabilitation Devices Market Overview
10.5.2 Middle East and Africa: Neurorehabilitation Devices Market – Revenue and Forecast to 2031 (US$ Million)
10.5.3 Middle East and Africa: Neurorehabilitation Devices Market – Revenue and Forecast Analysis – by Product Type
10.5.4 Middle East and Africa: Neurorehabilitation Devices Market – Revenue and Forecast Analysis – by Application
10.5.5 Middle East and Africa: Neurorehabilitation Devices Market – Revenue and Forecast Analysis – by End User
10.5.6 Middle East and Africa: Neurorehabilitation Devices Market – Revenue and Forecast Analysis – by Country
10.5.6.1 Saudi Arabia: Neurorehabilitation Devices Market – Revenue and Forecast to 2031 (US$ Million)
10.5.6.1.1 Saudi Arabia: Neurorehabilitation Devices Market Breakdown, by Product Type
10.5.6.1.2 Saudi Arabia: Neurorehabilitation Devices Market Breakdown, by Application
10.5.6.1.3 Saudi Arabia: Neurorehabilitation Devices Market Breakdown, by End User
10.5.6.2 South Africa: Neurorehabilitation Devices Market – Revenue and Forecast to 2031 (US$ Million)
10.5.6.2.1 South Africa: Neurorehabilitation Devices Market Breakdown, by Product Type
10.5.6.2.2 South Africa: Neurorehabilitation Devices Market Breakdown, by Application
10.5.6.2.3 South Africa: Neurorehabilitation Devices Market Breakdown, by End User
10.5.6.3 United Arab Emirates: Neurorehabilitation Devices Market – Revenue and Forecast to 2031 (US$ Million)
10.5.6.3.1 United Arab Emirates: Neurorehabilitation Devices Market Breakdown, by Product Type
10.5.6.3.2 United Arab Emirates: Neurorehabilitation Devices Market Breakdown, by Application
10.5.6.3.3 United Arab Emirates: Neurorehabilitation Devices Market Breakdown, by End User
10.5.6.4 Rest of Middle East and Africa: Neurorehabilitation Devices Market – Revenue and Forecast to 2031 (US$ Million)
10.5.6.4.1 Rest of Middle East and Africa: Neurorehabilitation Devices Market Breakdown, by Product Type
10.5.6.4.2 Rest of Middle East and Africa: Neurorehabilitation Devices Market Breakdown, by Application
10.5.6.4.3 Rest of Middle East and Africa: Neurorehabilitation Devices Market Breakdown, by End User
10.6 South and Central America
10.6.1 South and Central America Neurorehabilitation Devices Market Overview
10.6.2 South and Central America: Neurorehabilitation Devices Market – Revenue and Forecast to 2031 (US$ Million)
10.6.3 South and Central America: Neurorehabilitation Devices Market –Forecast Analysis – by Product Type
10.6.4 South and Central America: Neurorehabilitation Devices Market – Revenue and Forecast Analysis – by Application
10.6.5 South and Central America: Neurorehabilitation Devices Market – Revenue and Forecast Analysis – by End User
10.6.6 South and Central America: Neurorehabilitation Devices Market – Revenue and Forecast Analysis – by Country
10.6.6.1 Brazil: Neurorehabilitation Devices Market – Revenue and Forecast to 2031 (US$ Million)
10.6.6.1.1 Brazil: Neurorehabilitation Devices Market Breakdown, by Product Type
10.6.6.1.2 Brazil: Neurorehabilitation Devices Market Breakdown, by Application
10.6.6.1.3 Brazil: Neurorehabilitation Devices Market Breakdown, by End User
10.6.6.2 Argentina: Neurorehabilitation Devices Market – Revenue and Forecast to 2031 (US$ Million)
10.6.6.2.1 Argentina: Neurorehabilitation Devices Market Breakdown, by Product Type
10.6.6.2.2 Argentina: Neurorehabilitation Devices Market Breakdown, by Application
10.6.6.2.3 Argentina: Neurorehabilitation Devices Market Breakdown, by End User
10.6.6.3 Rest of South and Central America: Neurorehabilitation Devices Market – Revenue and Forecast to 2031 (US$ Million)
10.6.6.3.1 Rest of South and Central America: Neurorehabilitation Devices Market Breakdown, by Product Type
10.6.6.3.2 Rest of South and Central America: Neurorehabilitation Devices Market Breakdown, by Application
10.6.6.3.3 Rest of South and Central America: Neurorehabilitation Devices Market Breakdown, by End User
11. Neurorehabilitation Devices Market – Industry Landscape
11.1 Overview
11.2 Growth Strategies in Neurorehabilitation Devices Market
11.3 Organic Growth Strategies
11.3.1 Overview
11.4 Inorganic Growth Strategies
11.4.1 Overview
12. Company Profiles
12.1 Blackrock Microsystems Inc
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Hocoma AG
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Medtronic Plc
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Tyromotion GmbH
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Ekso Bionics Holdings Inc
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 BIONIK
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Abbott Laboratories
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 Renishaw Plc
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 EMOTIV
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
12.10 BioXtreme Ltd
12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Products and Services
12.10.4 Financial Overview
12.10.5 SWOT Analysis
12.10.6 Key Developments
13. Appendix
13.1 About The Insight Partners
13.2 Glossary of Terms
List of Tables
Table 1. Neurorehabilitation Devices Market Segmentation
Table 2. Neurorehabilitation Devices Market – Revenue and Forecast to 2031 (US$ Million) – by Product Type
Table 3. Neurorehabilitation Devices Market – Volume and Forecast to 2031 (Units) – by Product Type
Table 4. Neurorehabilitation Devices Market – Revenue and Forecast to 2031 (US$ Million) – by Application
Table 5. Neurorehabilitation Devices Market – Revenue and Forecast to 2031 (US$ Million) – by End User
Table 6. North America: Neurorehabilitation Devices Market – Revenue and Forecast to 2031(US$ Million) – by Product Type
Table 7. North America: Neurorehabilitation Devices Market – Volume and Forecast to 2031(Units) – by Product Type
Table 8. North America: Neurorehabilitation Devices Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 9. North America: Neurorehabilitation Devices Market – Revenue and Forecast to 2031(US$ Million) – by End User
Table 10. United States: Neurorehabilitation Devices Market – Revenue and Forecast to 2031(US$ Million) – by Product Type
Table 11. United States: Neurorehabilitation Devices Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 12. United States: Neurorehabilitation Devices Market – Revenue and Forecast to 2031(US$ Million) – by End User
Table 13. Canada: Neurorehabilitation Devices Market – Revenue and Forecast to 2031(US$ Million) – by Product Type
Table 14. Canada: Neurorehabilitation Devices Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 15. Canada: Neurorehabilitation Devices Market – Revenue and Forecast to 2031(US$ Million) – by End User
Table 16. Mexico: Neurorehabilitation Devices Market – Revenue and Forecast to 2031(US$ Million) – by Product Type
Table 17. Mexico: Neurorehabilitation Devices Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 18. Mexico: Neurorehabilitation Devices Market – Revenue and Forecast to 2031(US$ Million) – by End User
Table 19. Europe: Neurorehabilitation Devices Market – Revenue and Forecast to 2031(US$ Million) – by Product Type
Table 20. Europe: Neurorehabilitation Devices Market – Volume and Forecast to 2031(Units) – by Product Type
Table 21. Europe: Neurorehabilitation Devices Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 22. Europe: Neurorehabilitation Devices Market – Revenue and Forecast to 2031(US$ Million) – by End User
Table 23. United Kingdom: Neurorehabilitation Devices Market – Revenue and Forecast to 2031(US$ Million) – by Product Type
Table 24. United Kingdom: Neurorehabilitation Devices Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 25. United Kingdom: Neurorehabilitation Devices Market – Revenue and Forecast to 2031(US$ Million) – by End User
Table 26. Germany: Neurorehabilitation Devices Market – Revenue and Forecast to 2031(US$ Million) – by Product Type
Table 27. Germany: Neurorehabilitation Devices Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 28. Germany: Neurorehabilitation Devices Market – Revenue and Forecast to 2031(US$ Million) – by End User
Table 29. France: Neurorehabilitation Devices Market – Revenue and Forecast to 2031(US$ Million) – by Product Type
Table 30. France: Neurorehabilitation Devices Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 31. France: Neurorehabilitation Devices Market – Revenue and Forecast to 2031(US$ Million) – by End User
Table 32. Spain: Neurorehabilitation Devices Market – Revenue and Forecast to 2031(US$ Million) – by Product Type
Table 33. Spain: Neurorehabilitation Devices Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 34. Spain: Neurorehabilitation Devices Market – Revenue and Forecast to 2031(US$ Million) – by End User
Table 35. Italy: Neurorehabilitation Devices Market – Revenue and Forecast to 2031(US$ Million) – by Product Type
Table 36. Italy: Neurorehabilitation Devices Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 37. Italy: Neurorehabilitation Devices Market – Revenue and Forecast to 2031(US$ Million) – by End User
Table 38. Rest of Europe: Neurorehabilitation Devices Market – Revenue and Forecast to 2031(US$ Million) – by Product Type
Table 39. Rest of Europe: Neurorehabilitation Devices Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 40. Rest of Europe: Neurorehabilitation Devices Market – Revenue and Forecast to 2031(US$ Million) – by End User
Table 41. Asia Pacific: Neurorehabilitation Devices Market – Revenue and Forecast to 2031(US$ Million) – by Product Type
Table 42. Asia Pacific: Neurorehabilitation Devices Market – Volume and Forecast to 2031(Units) – by Product Type
Table 43. Asia Pacific: Neurorehabilitation Devices Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 44. Asia Pacific: Neurorehabilitation Devices Market – Revenue and Forecast to 2031(US$ Million) – by End User
Table 45. China: Neurorehabilitation Devices Market – Revenue and Forecast to 2031(US$ Million) – by Product Type
Table 46. China: Neurorehabilitation Devices Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 47. China: Neurorehabilitation Devices Market – Revenue and Forecast to 2031(US$ Million) – by End User
Table 48. Japan: Neurorehabilitation Devices Market – Revenue and Forecast to 2031(US$ Million) – by Product Type
Table 49. Japan: Neurorehabilitation Devices Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 50. Japan: Neurorehabilitation Devices Market – Revenue and Forecast to 2031(US$ Million) – by End User
Table 51. India: Neurorehabilitation Devices Market – Revenue and Forecast to 2031(US$ Million) – by Product Type
Table 52. India: Neurorehabilitation Devices Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 53. India: Neurorehabilitation Devices Market – Revenue and Forecast to 2031(US$ Million) – by End User
Table 54. Australia: Neurorehabilitation Devices Market – Revenue and Forecast to 2031(US$ Million) – by Product Type
Table 55. Australia: Neurorehabilitation Devices Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 56. Australia: Neurorehabilitation Devices Market – Revenue and Forecast to 2031(US$ Million) – by End User
Table 57. South Korea: Neurorehabilitation Devices Market – Revenue and Forecast to 2031(US$ Million) – by Product Type
Table 58. South Korea: Neurorehabilitation Devices Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 59. South Korea: Neurorehabilitation Devices Market – Revenue and Forecast to 2031(US$ Million) – by End User
Table 60. Rest of APAC: Neurorehabilitation Devices Market – Revenue and Forecast to 2031(US$ Million) – by Product Type
Table 61. Rest of APAC: Neurorehabilitation Devices Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 62. Rest of APAC: Neurorehabilitation Devices Market – Revenue and Forecast to 2031(US$ Million) – by End User
Table 63. Middle East and Africa: Neurorehabilitation Devices Market – Revenue and Forecast to 2031(US$ Million) – by Product Type
Table 64. Middle East and Africa: Neurorehabilitation Devices Market – Volume and Forecast to 2031(Units) – by Product Type
Table 65. Middle East and Africa: Neurorehabilitation Devices Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 66. Middle East and Africa: Neurorehabilitation Devices Market – Revenue and Forecast to 2031(US$ Million) – by End User
Table 67. Saudi Arabia: Neurorehabilitation Devices Market – Revenue and Forecast to 2031(US$ Million) – by Product Type
Table 68. Saudi Arabia: Neurorehabilitation Devices Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 69. Saudi Arabia: Neurorehabilitation Devices Market – Revenue and Forecast to 2031(US$ Million) – by End User
Table 70. South Africa: Neurorehabilitation Devices Market – Revenue and Forecast to 2031(US$ Million) – by Product Type
Table 71. South Africa: Neurorehabilitation Devices Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 72. South Africa: Neurorehabilitation Devices Market – Revenue and Forecast to 2031(US$ Million) – by End User
Table 73. United Arab Emirates: Neurorehabilitation Devices Market – Revenue and Forecast to 2031(US$ Million) – by Product Type
Table 74. United Arab Emirates: Neurorehabilitation Devices Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 75. United Arab Emirates: Neurorehabilitation Devices Market – Revenue and Forecast to 2031(US$ Million) – by End User
Table 76. Rest of Middle East and Africa: Neurorehabilitation Devices Market – Revenue and Forecast to 2031 (US$ Million) – by Product Type
Table 77. Rest of Middle East and Africa: Neurorehabilitation Devices Market – Revenue and Forecast to 2031 (US$ Million) – by Application
Table 78. Rest of Middle East and Africa: Neurorehabilitation Devices Market – Revenue and Forecast to 2031 (US$ Million) – by End User
Table 79. South and Central America: Neurorehabilitation Devices Market – Revenue and Forecast to 2031(US$ Million) – by Product Type
Table 80. South and Central America: Neurorehabilitation Devices Market – Volume and Forecast to 2031(Units) – by Product Type
Table 81. South and Central America: Neurorehabilitation Devices Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 82. South and Central America: Neurorehabilitation Devices Market – Revenue and Forecast to 2031(US$ Million) – by End User
Table 83. Brazil: Neurorehabilitation Devices Market – Revenue and Forecast to 2031(US$ Million) – by Product Type
Table 84. Brazil: Neurorehabilitation Devices Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 85. Brazil: Neurorehabilitation Devices Market – Revenue and Forecast to 2031(US$ Million) – by End User
Table 86. Argentina: Neurorehabilitation Devices Market – Revenue and Forecast to 2031(US$ Million) – by Product Type
Table 87. Argentina: Neurorehabilitation Devices Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 88. Argentina: Neurorehabilitation Devices Market – Revenue and Forecast to 2031(US$ Million) – by End User
Table 89. Rest of South and Central America: Neurorehabilitation Devices Market – Revenue and Forecast to 2031 (US$ Million) – by Product Type
Table 90. Rest of South and Central America: Neurorehabilitation Devices Market – Revenue and Forecast to 2031 (US$ Million) – by Application
Table 91. Rest of South and Central America: Neurorehabilitation Devices Market – Revenue and Forecast to 2031 (US$ Million) – by End User
Table 92. Recent Organic Growth Strategies in Neurorehabilitation Devices Market
Table 93. Recent Inorganic Growth Strategies in the Neurorehabilitation Devices Market
Table 94. Glossary of Terms, Neurorehabilitation Devices Market
List of Figures
Figure 1. Neurorehabilitation Devices Market Segmentation, by Geography
Figure 2. PEST Analysis
Figure 3. Average Selling Price, North America (US$/ Unit)
Figure 4. Average Selling Price, Europe (US$/ Unit)
Figure 5. Average Selling Price, Asia Pacific (US$/ Unit)
Figure 6. Average Selling Price, Rest of World (US$/ Unit)
Figure 7. Impact Analysis of Drivers and Restraints
Figure 8. Neurorehabilitation Devices Market Revenue (US$ Million), 2021–2031
Figure 9. Neurorehabilitation Devices Market Share (%) – by Product Type (2023 and 2031)
Figure 10. Neurorobotic System: Neurorehabilitation Devices Market – Revenue and Forecast to 2031 (US$ Million)
Figure 11. Brain Computer Interface: Neurorehabilitation Devices Market – Revenue and Forecast to 2031 (US$ Million)
Figure 12. Non-invasive Stimulators: Neurorehabilitation Devices Market – Revenue and Forecast to 2031 (US$ Million)
Figure 13. Wearable Devices: Neurorehabilitation Devices Market – Revenue and Forecast to 2031 (US$ Million)
Figure 14. Neurorehabilitation Devices Market Share (%) – by Application (2023 and 2031)
Figure 15. Stroke: Neurorehabilitation Devices Market – Revenue and Forecast to 2031 (US$ Million)
Figure 16. Traumatic Brain Injury: Neurorehabilitation Devices Market – Revenue and Forecast to 2031 (US$ Million)
Figure 17. Spinal Cord Injury: Neurorehabilitation Devices Market – Revenue and Forecast to 2031 (US$ Million)
Figure 18. Parkinsons Disease: Neurorehabilitation Devices Market – Revenue and Forecast to 2031 (US$ Million)
Figure 19. Cerebral Palsy: Neurorehabilitation Devices Market – Revenue and Forecast to 2031 (US$ Million)
Figure 20. Others: Neurorehabilitation Devices Market – Revenue and Forecast to 2031 (US$ Million)
Figure 21. Neurorehabilitation Devices Market Share (%) – by End User (2023 and 2031)
Figure 22. Rehabilitation Centers: Neurorehabilitation Devices Market – Revenue and Forecast to 2031 (US$ Million)
Figure 23. Hospitals and Clinics: Neurorehabilitation Devices Market – Revenue and Forecast to 2031 (US$ Million)
Figure 24. Home Care: Neurorehabilitation Devices Market – Revenue and Forecast to 2031 (US$ Million)
Figure 25. Neurorehabilitation Devices Market Breakdown by Region, 2023 and 2031 (%)
Figure 26. North America: Neurorehabilitation Devices Market – Revenue and Forecast to 2031(US$ Million)
Figure 27. North America: Neurorehabilitation Devices Market Breakdown, by Key Countries, 2023 and 2031 (%)
Figure 28. United States: Neurorehabilitation Devices Market – Revenue and Forecast to 2031(US$ Million)
Figure 29. Canada: Neurorehabilitation Devices Market – Revenue and Forecast to 2031(US$ Million)
Figure 30. Mexico: Neurorehabilitation Devices Market – Revenue and Forecast to 2031(US$ Million)
Figure 31. Europe: Neurorehabilitation Devices Market – Revenue and Forecast to 2031(US$ Million)
Figure 32. Europe: Neurorehabilitation Devices Market Breakdown, by Key Countries, 2023 and 2031 (%)
Figure 33. United Kingdom: Neurorehabilitation Devices Market – Revenue and Forecast to 2031(US$ Million)
Figure 34. Germany: Neurorehabilitation Devices Market – Revenue and Forecast to 2031(US$ Million)
Figure 35. France: Neurorehabilitation Devices Market – Revenue and Forecast to 2031(US$ Million)
Figure 36. Spain: Neurorehabilitation Devices Market – Revenue and Forecast to 2031(US$ Million)
Figure 37. Italy: Neurorehabilitation Devices Market – Revenue and Forecast to 2031(US$ Million)
Figure 38. Rest of Europe: Neurorehabilitation Devices Market – Revenue and Forecast to 2031(US$ Million)
Figure 39. Asia Pacific: Neurorehabilitation Devices Market – Revenue and Forecast to 2031(US$ Million)
Figure 40. Asia Pacific: Neurorehabilitation Devices Market Breakdown, by Key Countries, 2023 and 2031 (%)
Figure 41. China: Neurorehabilitation Devices Market – Revenue and Forecast to 2031(US$ Million)
Figure 42. Japan: Neurorehabilitation Devices Market – Revenue and Forecast to 2031(US$ Million)
Figure 43. India: Neurorehabilitation Devices Market – Revenue and Forecast to 2031(US$ Million)
Figure 44. Australia: Neurorehabilitation Devices Market – Revenue and Forecast to 2031(US$ Million)
Figure 45. South Korea: Neurorehabilitation Devices Market – Revenue and Forecast to 2031(US$ Million)
Figure 46. Rest of APAC: Neurorehabilitation Devices Market – Revenue and Forecast to 2031(US$ Million)
Figure 47. Middle East and Africa: Neurorehabilitation Devices Market – Revenue and Forecast to 2031(US$ Million)
Figure 48. Middle East and Africa: Neurorehabilitation Devices Market Breakdown, by Key Countries, 2023 and 2031 (%)
Figure 49. Saudi Arabia: Neurorehabilitation Devices Market – Revenue and Forecast to 2031(US$ Million)
Figure 50. South Africa: Neurorehabilitation Devices Market – Revenue and Forecast to 2031(US$ Million)
Figure 51. United Arab Emirates: Neurorehabilitation Devices Market – Revenue and Forecast to 2031(US$ Million)
Figure 52. Rest of Middle East and Africa: Neurorehabilitation Devices Market – Revenue and Forecast to 2031 (US$ Million)
Figure 53. South and Central America: Neurorehabilitation Devices Market – Revenue and Forecast to 2031(US$ Million)
Figure 54. South and Central America: Neurorehabilitation Devices Market Breakdown, by Key Countries, 2023 and 2031 (%)
Figure 55. Brazil: Neurorehabilitation Devices Market – Revenue and Forecast to 2031(US$ Million)
Figure 56. Argentina: Neurorehabilitation Devices Market – Revenue and Forecast to 2031(US$ Million)
Figure 57. Rest of South and Central America: Neurorehabilitation Devices Market – Revenue and Forecast to 2031 (US$ Million)
Figure 58. Growth Strategies in Neurorehabilitation Devices Market
The List of Companies - Neurorehabilitation Devices Market
- Blackrock Microsystems Inc
- Hocoma AG
- Medtronic Plc
- Tyromotion GmbH
- Ekso Bionics Holdings Inc
- BIONIK
- Abbott Laboratories
- Renishaw Plc
- EMOTIV
- BioXtreme Ltd.
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For